Shinhung (004080) - Net Assets
Based on the latest financial reports, Shinhung (004080) has net assets worth ₩116.48 Billion KRW (≈ $78.94 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩153.50 Billion ≈ $104.03 Million USD) and total liabilities (₩37.02 Billion ≈ $25.09 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 004080 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩116.48 Billion |
| % of Total Assets | 75.88% |
| Annual Growth Rate | 4.65% |
| 5-Year Change | 26.4% |
| 10-Year Change | 36.91% |
| Growth Volatility | 4.52 |
Shinhung - Net Assets Trend (2000–2024)
This chart illustrates how Shinhung's net assets have evolved over time, based on quarterly financial data. Also explore Shinhung assets under control for the complete picture of this company's asset base.
Annual Net Assets for Shinhung (2000–2024)
The table below shows the annual net assets of Shinhung from 2000 to 2024. For live valuation and market cap data, see 004080 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩116.16 Billion ≈ $78.72 Million |
+1.99% |
| 2023-12-31 | ₩113.89 Billion ≈ $77.18 Million |
+6.58% |
| 2022-12-31 | ₩106.86 Billion ≈ $72.42 Million |
+5.37% |
| 2021-12-31 | ₩101.42 Billion ≈ $68.73 Million |
+10.35% |
| 2020-12-31 | ₩91.90 Billion ≈ $62.28 Million |
+4.49% |
| 2019-12-31 | ₩87.95 Billion ≈ $59.61 Million |
+0.74% |
| 2018-12-31 | ₩87.31 Billion ≈ $59.17 Million |
+1.09% |
| 2017-12-31 | ₩86.37 Billion ≈ $58.53 Million |
+1.99% |
| 2016-12-31 | ₩84.68 Billion ≈ $57.39 Million |
-0.19% |
| 2015-12-31 | ₩84.85 Billion ≈ $57.50 Million |
+2.29% |
| 2014-12-31 | ₩82.95 Billion ≈ $56.21 Million |
+6.49% |
| 2013-12-31 | ₩77.89 Billion ≈ $52.79 Million |
+0.79% |
| 2012-12-31 | ₩77.28 Billion ≈ $52.37 Million |
-0.69% |
| 2011-12-31 | ₩77.82 Billion ≈ $52.74 Million |
+6.14% |
| 2009-12-31 | ₩73.32 Billion ≈ $49.69 Million |
-0.25% |
| 2008-12-31 | ₩73.51 Billion ≈ $49.81 Million |
+1.86% |
| 2007-12-31 | ₩72.16 Billion ≈ $48.90 Million |
+3.04% |
| 2006-12-31 | ₩70.03 Billion ≈ $47.46 Million |
+2.42% |
| 2005-12-31 | ₩68.38 Billion ≈ $46.34 Million |
+11.37% |
| 2004-12-31 | ₩61.40 Billion ≈ $41.61 Million |
+12.81% |
| 2003-12-31 | ₩54.43 Billion ≈ $36.89 Million |
+13.96% |
| 2002-12-31 | ₩47.76 Billion ≈ $32.37 Million |
+8.91% |
| 2001-12-31 | ₩43.85 Billion ≈ $29.72 Million |
+12.35% |
| 2000-12-31 | ₩39.03 Billion ≈ $26.45 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shinhung's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10267740459000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩102.68 Billion | 88.77% |
| Other Components | ₩12.99 Billion | 11.23% |
| Total Equity | ₩115.67 Billion | 100.00% |
Shinhung Competitors by Market Cap
The table below lists competitors of Shinhung ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Naim Holdings Bhd
KLSE:5073
|
$88.63 Million |
|
Big River Industries Ltd
AU:BRI
|
$88.64 Million |
|
Centro de Imagem Diagnósticos S.A
SA:AALR3
|
$88.77 Million |
|
Vytrus Biotech S.A.
MC:VYT
|
$88.79 Million |
|
Evergreen Max Cash Capital Berhad
KLSE:0286
|
$88.61 Million |
|
Indo Amines Limited
NSE:INDOAMIN
|
$88.60 Million |
|
ESGL Holdings Limited Ordinary Shares
NASDAQ:ESGL
|
$88.60 Million |
|
Peel Mining Ltd
AU:PEX
|
$88.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shinhung's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 113,890,708,950 to 115,668,884,700, a change of 1,778,175,750 (1.6%).
- Net income of 5,228,581,700 contributed positively to equity growth.
- Dividend payments of 2,497,964,210 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩5.23 Billion | +4.52% |
| Dividends Paid | ₩2.50 Billion | -2.16% |
| Other Changes | ₩-952.44 Million | -0.82% |
| Total Change | ₩- | 1.56% |
Book Value vs Market Value Analysis
This analysis compares Shinhung's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.14x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.55x to 1.14x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | ₩9053.16 | ₩13990.00 | x |
| 2018-12-31 | ₩9149.55 | ₩13990.00 | x |
| 2019-12-31 | ₩9215.71 | ₩13990.00 | x |
| 2020-12-31 | ₩9622.90 | ₩13990.00 | x |
| 2021-12-31 | ₩10782.66 | ₩13990.00 | x |
| 2022-12-31 | ₩11398.27 | ₩13990.00 | x |
| 2023-12-31 | ₩12063.93 | ₩13990.00 | x |
| 2024-12-31 | ₩12242.03 | ₩13990.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shinhung utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 4.52%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 5.14%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 1.22x
- Recent ROE (4.52%) is below the historical average (8.30%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | 20.59% | 9.85% | 0.88x | 2.39x | ₩3.97 Billion |
| 2001 | 17.92% | 8.27% | 1.03x | 2.11x | ₩3.34 Billion |
| 2002 | 15.85% | 7.18% | 0.99x | 2.23x | ₩2.71 Billion |
| 2003 | 16.95% | 8.13% | 0.99x | 2.10x | ₩3.67 Billion |
| 2004 | 17.60% | 9.05% | 1.07x | 1.82x | ₩4.54 Billion |
| 2005 | 13.05% | 7.12% | 1.03x | 1.78x | ₩2.03 Billion |
| 2006 | 9.26% | 4.45% | 1.06x | 1.97x | ₩-507.58 Million |
| 2007 | 6.26% | 2.79% | 1.17x | 1.92x | ₩-2.65 Billion |
| 2008 | 2.69% | 1.22% | 1.10x | 2.00x | ₩-5.30 Billion |
| 2009 | 2.22% | 1.01% | 1.14x | 1.92x | ₩-5.69 Billion |
| 2011 | 3.81% | 1.73% | 1.19x | 1.85x | ₩-4.76 Billion |
| 2012 | 1.31% | 0.65% | 1.09x | 1.84x | ₩-6.65 Billion |
| 2013 | 1.80% | 1.13% | 0.96x | 1.67x | ₩-6.35 Billion |
| 2014 | 8.15% | 5.43% | 1.01x | 1.49x | ₩-1.53 Billion |
| 2015 | 3.49% | 2.36% | 0.92x | 1.62x | ₩-5.52 Billion |
| 2016 | 1.36% | 0.93% | 0.95x | 1.55x | ₩-7.31 Billion |
| 2017 | 3.67% | 2.61% | 0.92x | 1.52x | ₩-5.47 Billion |
| 2018 | 3.50% | 2.51% | 0.92x | 1.52x | ₩-5.68 Billion |
| 2019 | 2.32% | 1.66% | 0.84x | 1.67x | ₩-6.75 Billion |
| 2020 | 13.53% | 10.66% | 0.80x | 1.59x | ₩3.24 Billion |
| 2021 | 13.26% | 10.60% | 0.92x | 1.37x | ₩3.31 Billion |
| 2022 | 7.92% | 7.16% | 0.84x | 1.32x | ₩-2.22 Billion |
| 2023 | 8.10% | 8.21% | 0.80x | 1.23x | ₩-2.16 Billion |
| 2024 | 4.52% | 5.14% | 0.72x | 1.22x | ₩-6.34 Billion |
Industry Comparison
This section compares Shinhung's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $106,653,871,011
- Average return on equity (ROE) among peers: -4.05%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shinhung (004080) | ₩116.48 Billion | 20.59% | 0.32x | $88.63 Million |
| HansBiomed Corporation (042520) | $33.89 Billion | -92.49% | 2.73x | $258.75 Million |
| JVM Co. Ltd (054950) | $104.90 Billion | 4.97% | 0.55x | $195.14 Million |
| Huvitz Co. Ltd (065510) | $78.68 Billion | 3.95% | 0.79x | $58.02 Million |
| Vieworks Co. Ltd (100120) | $126.17 Billion | 15.56% | 0.09x | $165.07 Million |
| Corentec Co Ltd (104540) | $60.18 Billion | 0.77% | 0.59x | $50.52 Million |
| Humasis Co. Ltd (205470) | $346.73 Billion | 52.67% | 0.35x | $61.42 Million |
| NH SPAC 2 (206640) | $151.09 Billion | 29.36% | 0.27x | $169.86 Million |
| Hana Must SPAC 2 (208370) | $26.92 Billion | -55.25% | 0.69x | $75.64 Million |
| DRTECH Corporation (214680) | $31.33 Billion | 3.98% | 0.59x | $98.45 Million |
About Shinhung
Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory p… Read more